Dr. Melmed is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5020 E Shea Blvd
Ste 100
Scottsdale, AZ 85254Phone+1 480-443-0050
Education & Training
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1979 - 1981- Boston Children’s Hospital/Boston Medical Center AFellowship, Developmental-Behavioral Pediatrics, 1981
One Brooklyn Health System/Brookdale University Hospital and Medical CenterResidency, Pediatrics, 1977 - 1979
University of Cape Town Faculty of MedicineClass of 1974
Certifications & Licensure
AZ State Medical License 1982 - 2025- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Developmental-Behavioral Pediatrics
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Safety, Tolerability and Efficacy Study of STX209 in Subjects With Fragile X Syndrome Start of enrollment: 2008 Nov 01
- Biomarker Testing and DNA Collection in Subjects Participating in Protocol 22001 Start of enrollment: 2009 Jan 01
- Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders Start of enrollment: 2009 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 27 citationsEvaluation of an artificial intelligence-based medical device for diagnosis of autism spectrum disorder.Jonathan T Megerian, Sangeeta Dey, Raun D Melmed, Daniel L Coury, Marc Lerner
NPJ Digital Medicine. 2022-05-05 - 24 citationsEfficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies.Antonio Y. Hardan, Robert L. Hendren, Michael G. Aman, Adelaide S. Robb, Raun D. Melmed
Autism. 2019-04-26 - 24 citationsThe SOFIA Study: Negative Multi-center Study of Low Dose Fluoxetine on Repetitive Behaviors in Children and Adolescents with Autistic Disorder.Paul Herscu, Benjamin L. Handen, L. Eugene Arnold, Snape Michael Frederick, Joel D. Bregman
Journal of Autism and Developmental Disorders. 2020-09-01
Press Mentions
FDA Approves Prescription-Only Video Game for Children with ADHDJune 17th, 2020
Akili Announces ENDEAVORTM Digital Attention Treatment Is Now Available for Children with Attention Deficit Hyperactivity Disorder (ADHD) Under FDA’s COVID-19 Enforcement Discretion GuidanceApril 22nd, 2020
Traveling with an Autistic Child: Tips to Make Your Trip EasierJanuary 15th, 2020- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
